Vojtech Parrák

Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial

Petr Novák, Reinhold Schmidt, Eva Kontseková et al. · The Lancet Neurology · 2016 · 302 citations

Medicine, Immunology, Neurology +12

ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer’s disease

Petr Novák, Branislav Kováčech, Stanislav Katina et al. · Nature Aging · 2021 · 172 citations · Full text

Life Sciences, Neurology, Neuroscience +15

FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer’s disease

Petr Novák, Reinhold Schmidt, Eva Kontseková et al. · Alzheimer s Research & Therapy · 2018 · 143 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +17

Association of metabolic syndrome risk factors with selected markers of oxidative status and microinflammation in healthy omnivores and vegetarians

Katarı́na Šebeková, Peter Boor, Martina Valachovičová et al. · Molecular Nutrition & Food Research · 2006 · 64 citations

Life Sciences, Nutrition, Nutritional Sciences +17

Quantitative analysis of phenylalanine, tyrosine, tryptophan and kynurenine in rat model for tauopathies by ultra-high performance liquid chromatography with fluorescence and mass spectrometry detection

Jaroslav Galba, Alena Michalicová, Vojtech Parrák et al. · Journal of Pharmaceutical and Biomedical Analysis · 2015 · 32 citations

Life Sciences, Biochemistry, Mass Spectrometric Analysis +15